source Post navigation COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in … – GlobeNewswire GLP-1R agonist liraglutide rapidly improves insulin sensitivity in pre-diabetics, independent of weight loss – News-Medical.Net